BioVie Inc. Repayment of Notes Receivable from Related Parties
BioVie Inc. (BIVI) reported Repayment of Notes Receivable from Related Parties of $244.30 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RepaymentOfNotesReceivableFromRelatedParties · last filed 2018-11-14
- BioVie Inc. repayment of notes receivable from related parties for the quarter ending 2018-09-30 was $244.30K.
| Period end | Repayment of Notes Receivable from Related Parties 3 month |
|---|---|
| 2018-09-30 | $244.30K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |